AVEOPharmaceuticals (AVEO)Human Response Platform™
tivozanibAVEO has submitted a new drug application (NDA)renal cell carcinoma (RCCcolorectal and breast cancers
RBC Capital thinks
Cash on Hand and Share Structure:
Aveo's goal with the FDA:
Onyx Pharmaceuticals (ONXX)
Progression-free survival
In a recent interviewwith another Seeking Alpha contributor, Michael Bailey, Chief Commercial Officer at Aveo Oncology, had the following to say about this result:
believes OS trended against
Johnson & Johnson (JNJ)
have shownDendreon's (DNDN)
Biogen Idec, Inc (BIIB)
Merck & Co (MRK)
*Price Target Summary:
*Data sourced from Yahoo Finance.
Disclosure: I am long AVEO. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.
Additional disclosure:Disclaimer: This article is intended for informational and entertainment use only, and should not be construed as professional investment advice. They are my opinions only. Trading stocks is risky -- always be sure to know and understand your risk tolerance. You can incur substantial financial losses in any trade or investment. Always do your own due diligence before buying and selling any stock, and/or consult with a licensed financial adviser.
tivozanibAVEO has submitted a new drug application (NDA)renal cell carcinoma (RCCcolorectal and breast cancers
RBC Capital thinks
Cash on Hand and Share Structure:
Aveo's goal with the FDA:
Onyx Pharmaceuticals (ONXX)
Progression-free survival
In a recent interviewwith another Seeking Alpha contributor, Michael Bailey, Chief Commercial Officer at Aveo Oncology, had the following to say about this result:
believes OS trended against
Johnson & Johnson (JNJ)
have shownDendreon's (DNDN)
Biogen Idec, Inc (BIIB)
Merck & Co (MRK)
*Price Target Summary:
*Data sourced from Yahoo Finance.
Disclosure: I am long AVEO. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.
Additional disclosure:Disclaimer: This article is intended for informational and entertainment use only, and should not be construed as professional investment advice. They are my opinions only. Trading stocks is risky -- always be sure to know and understand your risk tolerance. You can incur substantial financial losses in any trade or investment. Always do your own due diligence before buying and selling any stock, and/or consult with a licensed financial adviser.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.